Screener
Prime Medicine PRME Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Prime Medicine’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:03 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053883
| (in thousands, except share and per share amounts) | June 30,2026 | December 31,2025 |
|---|---|---|
| Other current assets | 376 | 674 |
| Total current assets | 96,804 | 181,293 |
| Property and equipment, net | 17,077 | 20,572 |
| Operating lease right-of-use assets | 120,468 | 126,177 |
| Restricted cash | 13,691 | 13,691 |
| Other assets | 1,000 | 1,000 |
| Total assets | $249,040 | $342,733 |
| Liabilities and Stockholders’ Equity |
Item 1. Financial Statements (unaudited)
FAQ
- What is Prime Medicine's operating lease ROU assets?
- Prime Medicine (PRME) reported operating lease ROU assets of $120.47M in Q2 2026.
- How has Prime Medicine's operating lease ROU assets changed year-over-year?
- Prime Medicine's operating lease ROU assets increased by 0.2% year-over-year, from $120.2M to $120.47M.
- What is the long-term trend for Prime Medicine's operating lease ROU assets?
- Over 5 years (2020 to 2025), Prime Medicine's operating lease ROU assets has grown at a 114.2% compound annual growth rate (CAGR), from $2.8M to $126.18M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Prime Medicine's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude